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Abstract 1 
The NLRP3 inflammasome is a multi-protein complex that assembles in response to 2 
tissue damage or infection, triggering activation of caspase-1, an enzyme that converts 3 
interleukin (IL)-1β into its active form. A role for the NLRP3 inflammasome is 4 
emerging in inflammatory pain, but its influence in other pain types is largely 5 
unexamined. Therefore the aim of this study was to assess the role of the NLRP3 6 
inflammasome and its downstream product caspase-1 in a mouse model of burn-7 
induced pain. A superficial burn was induced on the plantar surface of the left hind 8 
paw using a hot plate set at 52.5 °C for 25 seconds. Development of acute burn-9 
induced mechanical allodynia, thermal allodynia, edema and weight bearing changes 10 
was assessed in Nlrp3-/- and caspase-1-deficient (Ice-/-) mice, and in mice administered 11 
the selective NLRP3 inflammasome inhibitor MCC950. Burn-induced mechanical 12 
and thermal allodynia developed normally in Nlrp3-/- and Ice-/- mice and mice 13 
administered MCC950. Burn-induced edema was significantly reduced in Ice-/- mice 14 
only. Burn-induced weight bearing changes were attenuated in Nlrp3-/- mice and mice 15 
administered MCC950 72 h post burn injury only. This study suggests that NLRP3 16 
and its downstream product caspase-1 have a limited role in the development of burn-17 
induced pain. 18 
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1. Introduction 1 
Inflammasomes, which include NLRP1, NLRP3, NLRC4 and AIM2, are multi-2 
protein complexes that assemble in response to tissue damage or infection.  The 3 
NLRP3 inflammasome is of particular interest, as it is implicated in a range of 4 
autoimmune, inflammatory and metabolic diseases, including gout, diabetes and 5 
multiple sclerosis [1,2]. Once activated, the NLRP3 inflammasome triggers activation 6 
of caspase-1 (formally known as interleukin-1 converting enzyme; ICE), an enzyme 7 
that cleaves interleukins (IL)-1β and -18 into their active forms [1,3]. IL-1β is an 8 
important mediator of the inflammatory response, promoting fever, vasodilation and 9 
infiltration of immune cells into inflamed tissue [4]. In addition, IL-1β causes 10 
mechanical and thermal hypersensitivity when administered peripherally, through 11 
both direct activation of nociceptors and through upregulation of other pro-12 
nociceptive mediators, such nerve growth factor, cyclooxygenase type 2 and 13 
substance P [3-8].  14 
Burn injury triggers an acute inflammatory response, which can be restricted to the 15 
site of injury or involve systemic inflammatory processes, resulting in pain of a 16 
complex pathology that can be difficult to manage. IL-1β is has been reported to be 17 
present in the blister fluid of burns patients and elevated in plasma from humans with 18 
a burn injury, suggesting involvement of IL-1β in burn-induced pain [9-12]. In 19 
addition, transcripts of NLRP3 have been shown to be upregulated in the adipose 20 
tissue of burns patients, suggesting that the generation of IL-1β, which was also 21 
upregulated, may be a consequence of NLRP3/caspase-1-dependent pathways 22 
following burn injury [12]. However, the specific role of the NLRP3 inflammasome 23 
and its downstream products in burn-induced pain has not been assessed, and was the 24 
focus of the present study. Using a previously established mouse model of acute burn 25 
 4 
injury [13], we assessed burn-induced mechanical allodynia, thermal allodynia, edema 1 
and weight bearing changes in Nlrp3 and Ice knockout mice, and in mice administered 2 
the selective NLRP3 inflammasome inhibitor MCC950 [14].   3 
 4 
2. Methods 5 
2.1 Animals 6 
For behavioural assessment we used adult male Nlrp3-/- [15] and caspase-1-/-/caspase-7 
11null (Ice-/-) [16] mice aged 6-8 weeks, backcrossed on C57BL/6J background at least 8 
ten times, with age matched male C57BL/6J mice used as controls. Animals were 9 
housed in groups of 3 or 4 per cage, under 12 h light-dark cycles and had standard 10 
rodent chow and water ad libitum. All behavioural assessment was performed by a 11 
blinded investigator who was unaware of the genotype and/or treatments received.  12 
 13 
Ethical approval for in vivo experiments in animals was obtained from the University 14 
of Queensland animal ethics committee. Experiments involving animals were 15 
conducted in accordance with the Animal Care and Protection Regulation Qld (2012), 16 
the Australian Code of Practice for the Care and Use of Animals for Scientific 17 
Purposes, 8th edition (2013) and the International Association for the Study of Pain 18 
Guidelines for the Use of Animals in Research. 19 
 20 
2.2 Burn Injury Model 21 
To induce a mild superficial burn injury, the entire plantar surface of the left hind paw 22 
of mice was applied with firm pressure to a Peltier plate (Hot/Cold Plate, Ugo Basile, 23 
Comerio, Italy) set at 52.5 °C for 25 seconds under light isoflurane (3%) anaesthesia 24 
as previously described [13]. The resulting burn-injury caused localised erythema and 25 
 5 
edema, without the presence of blisters. Behavioural assessment was performed daily 1 
for three days after the burn injury. The same animals were used for each of the 2 
behavioural tests. Wild type animals were randomized to receive either MCC950 (50 3 
mg/kg) [14] or vehicle control (saline) administered by intraperitoneal injection (10 4 
μL/g) at the time of burn injury, then once daily for three days.  5 
 6 
2.3 Electronic von Frey 7 
Mechanical allodynia was assessed using an electronic von Frey apparatus 8 
(MouseMet Electronic von Frey, TopCat Metrology) as previously described [13]. 9 
Mice were habituated in individual mouse runs for at least 5 min prior to testing. A 10 
soft-tipped probe was applied to the plantar surface of each hind paw with pressured 11 
applied at a force rise rate of ~ 1 g/s. The force that elicited a paw withdrawal was 12 
determined by the MouseMet Software. The paw withdrawal force (PWF) was 13 
determined from the average of three tests, separated by at least 2 min.  14 
 15 
2.4 Hargreaves Test  16 
Mice were habituated individually in polyvinyl boxes (10 x 10 x 10 cm) placed on 17 
heated glass maintained at 25 °C for at least 30 min prior to behavioural assessment 18 
using the Hargreaves Test (Plantar Analgesia Meter, IITC, CA, USA). The radiant 19 
heat light source (intensity 15%) was focused on the plantar surface of each hind paw 20 
and the time taken for the mouse to withdraw the paw was recorded, with a cut-off of 21 
20 s to prevent tissue damage. The mean time to withdrawal was determined from the 22 
average of three tests, separated by at least 1 min.  23 
 24 
2.5 Paw Thickness  25 
 6 
Paw thickness was measured along the distal-proximal axis at the metatarsal level 1 
using a digital vernier caliper (Kincrome, Vic, Australia) whilst under light isoflurane 2 
(2%) anaesthesia. The paw thickness of the ipsilateral hind paw was normalised to the 3 
contralateral hind paw for each individual animal and measured 6 h following burn 4 
injury, then daily for 3 days.   5 
 6 
2.6 Weight bearing 7 
The Catwalk XT (Noldus Information Technology, The Netherlands) was used to 8 
assess weight-bearing behaviour. Mice were placed individually at one end an 9 
elevated enclosed glass walkway and allowed to walk freely to the other end, with a 10 
high-speed camera located below to record illuminated paw prints. Criteria for a 11 
successful run were a completion time of less than 10 s and a speed variance of less 12 
than 100 %. Three successful runs were recorded for each animal at each time point. 13 
Recordings were analysed using the Catwalk XT software using the paw pressure 14 
parameter ‘mean intensity of the 15 most intense pixels’ for the left hind paw as a 15 
measure of weight bearing. 16 
 17 
2.7 Data Analysis  18 
Data were plotted and analysed by GraphPad Prism, version 6.0. Statistical 19 
significance was defined as P < 0.05 and was determined by unpaired t-test assuming 20 
equal variance, one-way ANOVA with Dunnett’s post-test, or two-way ANOVA with 21 
Dunnett’s post-test; compared to wild type animals or vehicle control, as indicated. 22 
Data is expressed as the mean ± standard error of the mean (SEM). 23 
  24 
3. Results 25 
 7 
3.1 Basal mechanical and heat sensitivity is normal in Nlrp3-/- and Ice-/- mice 1 
To determine if NLRP3 or caspase-1 affect basal sensitivity, we assessed the 2 
mechanical and thermal thresholds of Nlrp3-/- and Ice-/- mice. Consistent with 3 
previous reports [17,18], no significant differences were found in basal mechanical 4 
thresholds (Figure 1A; PWF: wild type, 3.3 ± 0.3 g; Nlrp3-/-, 3.4 ± 0.4 g; Ice-/-, 3.8 ± 5 
0.3 g; P > 0.05) or basal heat thresholds (Figure 1B; time to withdrawal: wild type, 6 
12.8 ± 1.0 s; Nlrp3-/-, 14.1 ± 1.5 s; Ice-/-, 15.6 ± 1.2 s; P > 0.05) compared with wild 7 
type controls.  8 
 9 
3.2 Acute burn-induced mechanical allodynia develops normally in Nlrp3-/- and Ice-/- 10 
mice 11 
To determine the function of NLRP3 and caspase-1 in burn-induced mechanical 12 
allodynia, we assessed the mechanical thresholds of Nlrp3-/- and Ice-/- mice following 13 
burn injury. Burn-induced mechanical allodynia developed normally in both Nlrp3-/- 14 
(Figure 2A) and Ice-/- (Figure 2B) mice, with no significant differences compared to 15 
wild type controls at any of the time points tested. Consistent with the knock out data, 16 
the NLRP3 inflammasome inhibitor MCC950 also had no significant effect on burn-17 
induced mechanical allodynia compared to vehicle control (Figure 2C; PWT 72 h: 18 
control, 1.1 ± 0.1 g; MCC950, 1.3 ± 0.1 g; P > 0.05). 19 
 20 
3.3 Acute burn-induced thermal allodynia develops normally in Nlrp3-/- and Ice-/- 21 
mice 22 
To determine the role of NLRP3 and caspase-1 in burn-induced thermal allodynia, we 23 
assessed the thermal thresholds of Nlrp3-/- and Ice-/- mice following burn injury. Burn-24 
induced thermal allodynia developed normally in both Nlrp3-/- (Figure 3A) and Ice-/- 25 
 8 
(Figure 3B) mice, with no significant differences compared to wild type controls at 1 
any of the time points tested. Consistent with the knock out data, the NLRP3 2 
inflammasome inhibitor MCC950 did not significantly affect heat thresholds 3 
following burn injury compared to vehicle control (Figure 3C; Time to withdrawal 72 4 
h: control, 5.2 ± 0.7 s; MCC950, 3.9 ± 0.7 s; P > 0.05). 5 
 6 
3.4 Acute burn-induced edema is reduced in Ice-/- but not Nlrp3-/- mice 7 
To determine the role of NLRP3 and caspase-1 in the development of burn-induced 8 
edema, we assessed the paw thickness of Nlrp3-/- and Ice-/- mice following burn 9 
injury. Burn-induced edema developed normally in Nlrp3-/- mice (Figure 4A), but was 10 
significantly reduced in Ice-/- mice (Figure 4B) at 6 h (paw thickness: wild type, 176 ± 11 
7 %; Ice-/-, 143 ± 4 %, P < 0.05), 24 h (paw thickness: wild type, 135 ± 5 %; Ice-/-, 118 12 
± 4 %, P < 0.05) and 48 h (paw thickness: wild type, 130 ± 5 %; Ice-/-, 109 ± 4 %, P < 13 
0.05) post burn injury. Consistent with the data from Nlrp3-/- mice, MCC950 did not 14 
significantly affect the development of edema at any of the time points tested 15 
compared to vehicle control (Figure 4C).  16 
 17 
3.5 Acute burn-induced weight bearing changes are reduced in Nlrp3-/- mice  18 
To determine the role of NLRP3 and caspase-1 in the development of burn-induced 19 
reductions in weight bearing, we assessed the weight bearing behaviour of Nlrp3-/- 20 
and Ice-/- mice following burn injury. In the first 48 hours, no difference in weight 21 
bearing behaviour was observed between wild type and Nlrp3-/- mice, however there 22 
was a remarkable recovery to normal weight bearing behaviour in the ipsilateral hind 23 
paw of Nlrp3-/- mice at 72 h (Figure 5A; fluorescence 72 h: wild type 83 ± 7 %; 24 
Nlrp3-/-, 116 ± 7 %; P < 0.05). In Ice-/- mice, there was trend to increased weight 25 
 9 
bearing behaviour at all time points, however weight-bearing behaviour never 1 
returned to baseline values and was only statistically significant at 24 h (Figure 5B; 2 
fluorescence 24 h: wild type 75 ± 6 %; Ice-/-, 101 ± 8 %; P < 0.05). Consistent with 3 
the results from the Nlrp3-/- mice, administration of the NLRP3 inhibitor MCC950 4 
caused a remarkable recovery to normal weight bearing behaviour in the ipsilateral 5 
hind paw at 72 h compared to vehicle control (Figure 5C; fluorescence 72 h: control, 6 
94 ± 6 %; MCC950, 120 ± 2 %; P < 0.05). 7 
 8 
4. Discussion 9 
The potential contribution of the NLRP3 inflammasome to acute burn-induced pain 10 
has not been assessed previously. Here, we describe for the first time the development 11 
of mechanical allodynia, thermal allodynia, edema and changes in weight bearing 12 
behaviour in Nlrp3-/- and Ice-/- mice, as well as mice administered the selective 13 
NLRP3 inhibitor MCC950, following a superficial burn injury to the plantar surface 14 
of the hind paw.  15 
Mechanical and thermal allodynia developed normally in Nlrp3-/- mice, Ice-/- mice, 16 
and mice administered the NLRP3 inhibitor MCC950, indicating that the NLRP3 17 
inflammasome and its downstream product caspase-1 have a limited role in stimulus-18 
evoked burn-induced pain. This is clinically relevant, as stimulus-evoked pain may 19 
reflect pain related to dressing changes, baths and debridement, which often reaches 20 
quite intense levels and is difficult to manage in burns patients [19]. Similar results 21 
have been found in other pain models, with mechanical and thermal allodynia 22 
developing normally in Nlrp3-/- mice following spared nerve injury and no reduction 23 
in spontaneous pain behaviours in Nlrp3-/- mice following formalin injection [17]. 24 
Although we observed a limited effect on stimulus-evoked pain, Nlrp3-/- mice and 25 
 10 
mice administered MCC950 exhibited a profound recovery to normal weight bearing 1 
behaviour in the burn-injured hind paw 72 h post-burn, which was not present in the 2 
Ice-/- mice. Almost all NLRP3 functions require caspase-1; notable exceptions are 3 
NLRP3-dependent transcriptional regulation in CD4+ T cells, and NLRP3/caspase-8-4 
dependent apoptotic cell death [20,21]. Weight bearing may provide a model of 5 
background or non-stimulus evoked pain in the clinic, but it is currently unclear which 6 
caspase-1-independent pathway was elicited by NLRP3 in this case. Future studies 7 
could investigate potential functions for NLRP3-regulated Th2 cell differentiation or 8 
NLRP3-dependent caspase-8 activation in this context.  9 
Interestingly, burn-induced edema was significantly reduced in Ice-/- mice but not in 10 
Nlrp3-/- mice or mice treated with the selective NLRP3 inhibitor MCC950. This 11 
indicates that caspase-1 substrates, likely IL-1β, drive burn-induced inflammation, but 12 
caspase-1 is activated through NLRP3-independent pathways. This was surprising, 13 
given that NLRP3 is considered the main sensor of sterile inflammatory stimuli, 14 
which is inflammation triggered by tissue damage in the absence of infection [22]. 15 
Caspase-1 can be activated by other inflammasomes other than NLRP3, for example, 16 
NLRP1, NLRC4 and AIM2, although it is unclear which inflammasome is likely to be 17 
involved in burns injury [1]. 18 
Despite an upregulation of mature IL-1β reported following burn-injury, we have 19 
found that NLRP3 and caspase-1 have a limited role in burn-induced pain. Although 20 
caspase-1-independent processing of mature IL-1β cannot be ruled out [23], based on 21 
our results it seems unlikely that IL-1β is a major contributor to burn-induced pain. In 22 
addition, IL-1β is not consistently reported to be elevated following burn-injury 23 
[24,25].  Another cytokine that is upregulated following burn injury that is of 24 
particular interest is IL-6 [9,24,25]. IL-6 is a key mediator of inflammation, directly 25 
 11 
acts on nociceptors, and IL-6 deficiency suppresses the development of mechanical 1 
and thermal hypersensitivity following chronic nerve injury [24,26,27]. In a rat model 2 
of burn injury, intrathecal administration of antisense oligodeoxynucleotide against 3 
glycoprotein 130 (gp130), a key protein necessary for the IL-6/IL-6 receptor-4 
signalling complex, significantly reduced burn-induced mechanical allodynia, 5 
confirming a role for IL-6 specifically in burn-induced pain [24].  6 
Evidence is emerging that sex-related differences in immune system function can 7 
impact on pain behaviour in mice [28], however sex-related differences in the 8 
activation of the NLRP3 inflammasome have not been reported. As this study was 9 
performed using male mice only, a role for the NLRP3 inflammasome in female burn-10 
induced pain cannot be ruled out. 11 
In conclusion, we have demonstrated that NLRP3 and its downstream product 12 
caspase-1 have a limited role in the development of acute burn-induced pain and that 13 
pharmacological inhibition of NLRP3 is unlikely to be an effective treatment strategy 14 
for the treatment of acute procedural pain or inflammation in burn-injured patients.  15 
 16 
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Figure Legends 1 
 2 
Figure 1. Basal mechanical and thermal sensitivity of Nlrp3-/- and Ice-/- mice. (A) 3 
Mechanical thresholds assessed by electronic von Frey and (B) thermal thresholds 4 
assessed by the Hargreaves test. Statistical significance was determined using one-5 
way ANOVA with Dunnett’s post-test; * P < 0.05 compared to wild type (wt) control.  6 
Data is presented as mean ± SEM, n = 6-8 per group.  7 
 8 
Figure 2. Development of burn-induced mechanical allodynia in Nlrp3-/- and Ice-/- 9 
mice. (A) Time course of development of mechanical allodynia in Nlrp3-/- mice. 10 
Statistical significance was determined using two-way ANOVA with Dunnett’s post-11 
test. (B) Time course of development of mechanical allodynia in Ice-/- mice. Statistical 12 
significance was determined using two-way ANOVA with Dunnett’s post-test. (C) 13 
Effect of MCC950 on mechanical thresholds 72 h post burns injury. Dashed line 14 
represents baseline mechanical threshold. Statistical significance was determined 15 
using t-test. * P < 0.05 compared to wild type (wt) or vehicle control. Data is 16 
presented as mean ± SEM, n = 5-6 per group.  17 
 18 
Figure 3. Development of burn-induced thermal allodynia in Nlrp3-/- and Ice-/- mice. 19 
(A) Time course of development of thermal allodynia in Nlrp3-/- mice. Statistical 20 
significance was determined using two-way ANOVA with Dunnett’s post-test. (B) 21 
Time course of development of thermal allodynia in Ice-/- mice. Statistical 22 
significance was determined using two-way ANOVA with Dunnett’s post-test. (C) 23 
Effect of MCC950 on thermal thresholds 72 h post burns injury. Dashed line 24 
represents baseline thermal threshold. Statistical significance was determined using t-25 
 16 
test. * P < 0.05 compared to wild type (wt) or vehicle control.  Data is presented as 1 
mean ± SEM, n = 5-6 per group.  2 
 3 
Figure 4. Development of burn-induced edema in Nlrp3-/- and Ice-/- mice. (A) Time 4 
course of development of edema in Nlrp3-/- mice. (B) Time course of development of 5 
edema in Ice-/- mice. (C) Time course of development of edema in mice administered 6 
MCC950. Statistical significance was determined using two-way ANOVA with 7 
Dunnett’s post-test; * P < 0.05 compared to wild type (wt) or vehicle control. Data is 8 
presented as mean ± SEM, n = 5-6 per group. 9 
 10 
Figure 5. Burn-induced changes in weight bearing in Nlrp3-/- and Ice-/- mice. (A) 11 
Time course of changes in weight bearing in Nlrp3-/- mice. (B) Time course of 12 
changes in weight bearing in Ice-/- mice. (C) Time course of changes in weight 13 
bearing in mice administered MCC950. Statistical significance was determined using 14 
two-way ANOVA with Dunnett’s post-test; * P < 0.05 compared to wild type (wt) or 15 
vehicle control. Data is presented as mean ± SEM, n = 5-6 per group. 16 
